Observational studyMedicine2026
Trends and disparities in hepatorenal syndrome related mortality among adults ≥15 years in the United States: A retrospective observational study.
Observational study in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatorenal syndrome (HRS) is characterized by severe renal dysfunction associated with decompensated liver cirrhosis, leading to high morbidity and mortality. This study aims to assess disparities in HRS-related mortality stratified by sex, race/ethnicity, and geographic location in the U.S. We analyzed death certificate data from the CDC WONDER database for adults aged ≥ 15 years. Age adjusted mortality rates (AAMRs) per 1,000,000 population were calculated. Joinpoint regression was used to assess annual percent change (APC) in AAMRs, with P < .05 considered significant. A total of 95,537 deaths were attributed to HRS-related mortality between 1999 and 2020. The overall AAMR declined from 1999 to 2007 (APC: -3.70; 95% CI: -5.14 to -2.84) followed by stable trend till 2018 (APC: 0.13; 95% CI: -0.74 to 0.87) and then showed a sudden increase till 2020 (APC: 9.16; 95% CI: 3.48-11.89). Men had higher AAMR than women. Non-Hispanic (NH) American Indians or Alaska Natives displayed the highest AAMR, followed by Hispanic or Latinos, NH Whites, NH Black or African Americans and NH Asian or Pacific Islander. Variations were evident across regions with the West region having highest AAMR, followed by South, Northeast and Midwest regions. Mortality was the highest in nonmetropolitan areas. HRS-related mortality in the U.S. has increased since 2018, with significant disparities across sex, race/ethnicity and region. Improving healthcare access in underserved areas is essential to addressing disparities and reducing the burden of HRS-related mortality among high-risk populations in the U.S.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.